1296 related articles for article (PubMed ID: 31699526)
1. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
[TBL] [Abstract][Full Text] [Related]
3. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
[TBL] [Abstract][Full Text] [Related]
5. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
[TBL] [Abstract][Full Text] [Related]
6. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
Bicchetti M; Simone G; Giannarini G; Girometti R; Briganti A; Brunocilla E; Cardone G; De Cobelli F; Gaudiano C; Del Giudice F; Flammia S; Leonardo C; Pecoraro M; Schiavina R; Catalano C; Panebianco V
Radiol Med; 2022 Aug; 127(8):881-890. PubMed ID: 35763251
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of vesical imaging-reporting and data system (VI-RADS) in non-muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc transurethral resection: A prospective study.
El-Karamany TM; Al-Adl AM; Hosny MM; A Eldeep H; El-Hamshary SA
Urol Oncol; 2022 Oct; 40(10):454.e1-454.e7. PubMed ID: 35466036
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review.
Carando R; Afferi L; Marra G; Krajewski W; Pagliarulo V; Abufaraj M; Xylinas E; Cathelineau X; Sanchez-Salas R; Moschini M
Arab J Urol; 2020 Mar; 18(2):67-71. PubMed ID: 33029409
[TBL] [Abstract][Full Text] [Related]
9. Is high accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) sufficient for its implementation in the urological practice?
Rysankova K; Hanzlikova P; Zidlik V; Vrtkova A; Slisarenko M; Skarda J; Grepl M; Krhut J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar; 167(1):85-90. PubMed ID: 36628563
[TBL] [Abstract][Full Text] [Related]
10. Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
Hong SB; Lee NK; Kim S; Son IW; Ha HK; Ku JY; Kim KH; Park WY
J Magn Reson Imaging; 2020 Oct; 52(4):1249-1256. PubMed ID: 32220105
[TBL] [Abstract][Full Text] [Related]
11. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
[No Abstract] [Full Text] [Related]
12. Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study.
Marchioni M; Primiceri G; Delli Pizzi A; Basilico R; Berardinelli F; Mincuzzi E; Castellucci R; Sessa B; Di Nicola M; Schips L
Clin Genitourin Cancer; 2020 Oct; 18(5):409-415.e1. PubMed ID: 32273236
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.
Jazayeri SB; Dehghanbanadaki H; Hosseini M; Taghipour P; Alam MU; Balaji KC; Bandyk M
Urol Oncol; 2022 Feb; 40(2):45-55. PubMed ID: 34895996
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
Kazan O; Gunduz N; Bakir B; Iplikci A; Culpan M; Ersoy B; Yildirim A
Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
[TBL] [Abstract][Full Text] [Related]
15. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
Ye L; Chen Y; Xu H; Xie H; Yao J; Liu J; Song B
Eur Radiol; 2022 Sep; 32(9):6480-6492. PubMed ID: 35362750
[TBL] [Abstract][Full Text] [Related]
16. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of multiparametric MRI based Vesical Imaging-Reporting and Data System (VI-RADS) scoring in discriminating between non-muscle invasive and muscle invasive bladder cancer.
Islam NU; Jehangir M; Parry AH; Nazir SS; Bilal S
Pol J Radiol; 2023; 88():e356-e364. PubMed ID: 37701172
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
Ueno Y; Takeuchi M; Tamada T; Sofue K; Takahashi S; Kamishima Y; Hinata N; Harada K; Fujisawa M; Murakami T
Eur Urol; 2019 Jul; 76(1):54-56. PubMed ID: 30922688
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
Woo S; Panebianco V; Narumi Y; Del Giudice F; Muglia VF; Takeuchi M; Ghafoor S; Bochner BH; Goh AC; Hricak H; Catto JWF; Vargas HA
Eur Urol Oncol; 2020 Jun; 3(3):306-315. PubMed ID: 32199915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
